• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项在印度南部一家三级护理医院中应用 Cox 比例风险模型研究影响 COVID-19 患者住院时间的因素的研究。

A Study of Factors Affecting the Length of Hospital Stay of COVID-19 Patients by Cox-Proportional Hazard Model in a South Indian Tertiary Care Hospital.

机构信息

Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, India.

Joint Director of Collegiate Education, Chennai Region, Chennai, Tamil Nadu, India.

出版信息

J Prim Care Community Health. 2021 Jan-Dec;12:21501327211000231. doi: 10.1177/21501327211000231.

DOI:10.1177/21501327211000231
PMID:33729040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7975448/
Abstract

BACKGROUND

The objective of the study was to identify the factors that alter the length of hospital stay of COVID-19 patients so we have an estimate of the duration of hospitalization of patients. To achieve this, we used a time to event analysis to arrive at factors that could alter the length of hospital stay, aiding in planning additional beds for any future rise in cases.

METHODS

Information about COVID-19 patients was collected between June and August 2020. The response variable was the time from admission to discharge of patients. Cox proportional hazard model was used to identify the factors that were associated with the length of hospital stay.

RESULTS

A total of 730 COVID-19 patients were included, of which 675 (92.5%) recovered and 55 (7.5%) were considered to be right-censored, that is, the patient died or was discharged against medical advice. The median length of hospital stay of COVID-19 patients who were hospitalized was found to be 7 days by the Kaplan Meier curve. The covariates that prolonged the length of hospital stay were found to be abnormalities in oxygen saturation (HR = 0.446,  < .001), neutrophil-lymphocyte ratio (HR = 0.742,  = .003), levels of D-dimer (HR = 0.60,  = .002), lactate dehydrogenase (HR = 0.717,  = .002), and ferritin (HR = 0.763,  = .037). Also, patients who had more than 2 chronic diseases had a significantly longer length of stay (HR = 0.586,  = .008) compared to those with no comorbidities.

CONCLUSION

Factors that are associated with prolonged length of hospital stay of patients need to be considered in planning bed strength on a contingency basis.

摘要

背景

本研究旨在确定影响 COVID-19 患者住院时间长短的因素,以便我们能够预估患者的住院时间。为此,我们采用生存时间分析来确定可能改变住院时间的因素,以便为未来病例增加做好床位规划。

方法

我们于 2020 年 6 月至 8 月期间收集 COVID-19 患者的信息。因变量为患者入院至出院的时间。我们采用 Cox 比例风险模型来确定与住院时间长短相关的因素。

结果

共纳入 730 例 COVID-19 患者,其中 675 例(92.5%)痊愈,55 例(7.5%)被视为右删失,即患者死亡或未经医嘱提前出院。Kaplan-Meier 曲线显示 COVID-19 患者的中位住院时间为 7 天。结果发现,氧饱和度异常(HR=0.446, < .001)、中性粒细胞与淋巴细胞比值(HR=0.742, = .003)、D-二聚体(HR=0.60, = .002)、乳酸脱氢酶(HR=0.717, = .002)和铁蛋白(HR=0.763, = .037)水平升高会延长住院时间。此外,与无合并症的患者相比,患有 2 种及以上慢性疾病的患者的住院时间明显更长(HR=0.586, = .008)。

结论

在根据需要规划床位时,需要考虑与患者住院时间延长相关的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314f/7975448/3eef90b78dd3/10.1177_21501327211000231-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314f/7975448/3eef90b78dd3/10.1177_21501327211000231-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314f/7975448/3eef90b78dd3/10.1177_21501327211000231-fig1.jpg

相似文献

1
A Study of Factors Affecting the Length of Hospital Stay of COVID-19 Patients by Cox-Proportional Hazard Model in a South Indian Tertiary Care Hospital.一项在印度南部一家三级护理医院中应用 Cox 比例风险模型研究影响 COVID-19 患者住院时间的因素的研究。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211000231. doi: 10.1177/21501327211000231.
2
Patient Flow Dynamics in Hospital Systems During Times of COVID-19: Cox Proportional Hazard Regression Analysis.新冠疫情期间医院系统中的患者流动动态:Cox 比例风险回归分析。
Front Public Health. 2020 Dec 8;8:585850. doi: 10.3389/fpubh.2020.585850. eCollection 2020.
3
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.心力衰竭对因 COVID-19 住院患者的临床病程和结局的影响。意大利 Cardio-COVID 多中心研究的结果。
Eur J Heart Fail. 2020 Dec;22(12):2238-2247. doi: 10.1002/ejhf.2052. Epub 2020 Nov 27.
4
COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.卡纳塔克邦的 COVID-19 住院患者:生存和住院特征。
Indian J Public Health. 2020 Jun;64(Supplement):S221-S224. doi: 10.4103/ijph.IJPH_486_20.
5
A retrospective cohort study of 238,000 COVID-19 hospitalizations and deaths in Brazil.一项对 23.8 万例巴西 COVID-19 住院和死亡病例的回顾性队列研究。
Sci Rep. 2022 Mar 7;12(1):3629. doi: 10.1038/s41598-022-07538-0.
6
What are the risk factors of hospital length of stay in the novel coronavirus pneumonia (COVID-19) patients? A survival analysis in southwest China.在中国西南部,新型冠状病毒肺炎(COVID-19)患者的住院时间延长的危险因素有哪些?一项生存分析。
PLoS One. 2022 Jan 14;17(1):e0261216. doi: 10.1371/journal.pone.0261216. eCollection 2022.
7
Characteristics and outcomes of patients with COVID-19 admitted to ICU in a tertiary hospital in Stockholm, Sweden.瑞典斯德哥尔摩一家三级医院 ICU 收治的 COVID-19 患者的特征和结局。
Acta Anaesthesiol Scand. 2021 Jan;65(1):76-81. doi: 10.1111/aas.13694. Epub 2020 Sep 15.
8
Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients.出院后 COVID-19 存活者:家庭健康接受者的症状、功能和不良结局。
Ann Intern Med. 2021 Mar;174(3):316-325. doi: 10.7326/M20-5206. Epub 2020 Nov 24.
9
Modeling the recovery time of patients with coronavirus disease 2019 using an accelerated failure time model.利用加速失效时间模型对新型冠状病毒肺炎患者的康复时间进行建模。
J Int Med Res. 2021 Aug;49(8):3000605211040263. doi: 10.1177/03000605211040263.
10
Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score-matching analysis.高血压对中国武汉成年 COVID-19 住院患者结局的影响:倾向评分匹配分析。
Respir Res. 2020 Jul 6;21(1):172. doi: 10.1186/s12931-020-01435-8.

引用本文的文献

1
The impact of the COVID-19 pandemic on governmental hospitals performance indicators in city of Yazd, Iran: an interrupted time-series analysis.2019年冠状病毒病大流行对伊朗亚兹德市公立医院绩效指标的影响:一项中断时间序列分析
BMC Health Serv Res. 2025 Mar 26;25(1):438. doi: 10.1186/s12913-025-12587-y.
2
The predictive value of the LDH-albumin ratio on poor clinical course and mortality in COVID-19 patients: A single-center study.乳酸脱氢酶与白蛋白比值对新冠病毒肺炎患者不良临床病程及死亡率的预测价值:一项单中心研究
Medicine (Baltimore). 2025 Feb 28;104(9):e41660. doi: 10.1097/MD.0000000000041660.
3
Time to recovery of COVID-19 patients and its predictors: a retrospective cohort study in HUCSH, Sidama, Ethiopia.

本文引用的文献

1
Corticosteroids for COVID-19: the search for an optimum duration of therapy.用于治疗新型冠状病毒肺炎的皮质类固醇:寻找最佳治疗时长
Lancet Respir Med. 2021 Jan;9(1):e8. doi: 10.1016/S2213-2600(20)30530-0. Epub 2020 Nov 26.
2
COVID-19 mortality risk for older men and women.COVID-19 对老年男性和女性的死亡率风险。
BMC Public Health. 2020 Nov 19;20(1):1742. doi: 10.1186/s12889-020-09826-8.
3
A survival analysis of COVID-19 in the Mexican population.墨西哥人群 COVID-19 生存分析。
新冠病毒疾病患者的康复时间及其预测因素:埃塞俄比亚锡达马胡胡谢医院的一项回顾性队列研究
BMC Public Health. 2025 Jan 7;25(1):74. doi: 10.1186/s12889-024-21229-7.
4
Joint modeling of longitudinal and competing risks for assessing blood oxygen saturation and its association with survival outcomes in COVID-19 patients.用于评估新冠肺炎患者血氧饱和度及其与生存结局关联的纵向和竞争风险联合建模
J Educ Health Promot. 2024 Mar 28;13:91. doi: 10.4103/jehp.jehp_246_23. eCollection 2024.
5
Immediate cause and the role of multimorbidity in deaths associated with COVID 19 among hospitalized patients in a low resource district in Kerala India: A record-based case-control analysis.印度喀拉拉邦一个资源匮乏地区住院患者中与新冠病毒病相关死亡的直接原因及多种疾病的作用:基于记录的病例对照分析
J Family Med Prim Care. 2023 Aug;12(8):1593-1601. doi: 10.4103/jfmpc.jfmpc_2061_22. Epub 2023 Aug 29.
6
Association of vaccination status with the clinicobiochemical profile, hospital stay, and mortality in COVID-19: A case-control study.COVID-19疫苗接种状况与临床生化指标、住院时间和死亡率的关联:一项病例对照研究。
Health Sci Rep. 2023 Sep 25;6(9):e1579. doi: 10.1002/hsr2.1579. eCollection 2023 Sep.
7
Time to Recovery from COVID-19 and Its Predictors in Patients Hospitalized at Tibebe Ghion Specialized Hospital Care and Treatment Center, A Retrospective Follow-Up Study, North West Ethiopia.在提比贝格洪专科医院护理和治疗中心住院的 COVID-19 患者的康复时间及其预测因素:一项回顾性随访研究,埃塞俄比亚西北部。
Glob Health Epidemiol Genom. 2023 Sep 12;2023:5586353. doi: 10.1155/2023/5586353. eCollection 2023.
8
Factors Affecting Hospitalization Length and in-Hospital Death Due to COVID-19 Infection in Saudi Arabia: A Single-Center Retrospective Analysis.沙特阿拉伯新冠肺炎感染导致住院时间和院内死亡的影响因素:单中心回顾性分析
Int J Gen Med. 2023 Aug 1;16:3267-3280. doi: 10.2147/IJGM.S418243. eCollection 2023.
9
Bayesian model averaging for predicting factors associated with length of COVID-19 hospitalization.贝叶斯模型平均法预测与 COVID-19 住院时间相关的因素。
BMC Med Res Methodol. 2023 Jul 6;23(1):163. doi: 10.1186/s12874-023-01981-x.
10
Factors Affecting Confirmed COVID-19 Patient's Recovery Time at King Abdulaziz Medical City, Jeddah.影响吉达阿卜杜勒阿齐兹国王医疗城新冠肺炎确诊患者康复时间的因素
Cureus. 2023 Jan 24;15(1):e34130. doi: 10.7759/cureus.34130. eCollection 2023 Jan.
BMC Public Health. 2020 Oct 27;20(1):1616. doi: 10.1186/s12889-020-09721-2.
4
Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital.了解非重症 COVID-19 患者住院时间长短的影响因素:方仓庇护医院的回顾性队列研究。
PLoS One. 2020 Oct 21;15(10):e0240959. doi: 10.1371/journal.pone.0240959. eCollection 2020.
5
Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients.症状发作、住院和康复或死亡之间的时间:比利时 COVID-19 患者的统计分析。
Int J Environ Res Public Health. 2020 Oct 17;17(20):7560. doi: 10.3390/ijerph17207560.
6
COVID-19 length of hospital stay: a systematic review and data synthesis.COVID-19 住院时间:系统评价和数据综合。
BMC Med. 2020 Sep 3;18(1):270. doi: 10.1186/s12916-020-01726-3.
7
COVID-19 pandemic and its recovery time of patients in India: A pilot study.印度的新冠疫情及其患者康复时间:一项初步研究。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1205-1211. doi: 10.1016/j.dsx.2020.07.004. Epub 2020 Jul 9.
8
Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.与越南 COVID-19 患者住院时间相关的因素:生存分析。
Epidemiol Infect. 2020 Jun 10;148:e114. doi: 10.1017/S0950268820001259.
9
COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.卡纳塔克邦的 COVID-19 住院患者:生存和住院特征。
Indian J Public Health. 2020 Jun;64(Supplement):S221-S224. doi: 10.4103/ijph.IJPH_486_20.
10
Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China.中国武汉 109 例 COVID-19 肺炎逝者的住院和重症监护情况
Ann Am Thorac Soc. 2020 Jul;17(7):839-846. doi: 10.1513/AnnalsATS.202003-225OC.